Guest guest Posted September 28, 2011 Report Share Posted September 28, 2011 > Jeff wrote the following: " They're actually billing me for CAT scans required for the clinical trial, blood work, etc, in addition to the infusions of Ofatumumab. They're deducting what my insurance company covers, and telling me I'm responsible for the rest. " Is it no wonder that the participation in Clinical Trials is so low in the US? I just got off the phone with a fellow participant in a PCI Trial who asked if I had been billed for CT scans required by the Clinical Trial? I had not as yet but I have been a Lab-Rat for only just under three months. When entering a Clinical Trial you will be asked to read and sign a contract of sorts in which you are acknowledging the terms and conditions of your participation to include what is expected of you regarding your financial responsibilities that are defined as part of your " standard of care " . I will copy the following part of my agreement for my PCI Trial to try and make the case that patients with lymphadenopathy (SLL part of CLL) going into a Clinical Trial under my agreement should not be financially obligated by CT scan costs. Here is what my agreement states under the title " COSTS " " The study drug, PCI-32765, will be provided by the sponsor, Pharmacyclics, Inc. The tests that are exclusively done for the research will not be billed to you or your insurance company. These include research blood draws which will be testing to see how much of the study drug is in your blood and how your body is reacting to the study drug. The ECG's and the urine tests, T/B/NK Cell Count, Serum Ig, and PET/CT scans for SLL subjects done during the study are considered research and will be paid for by the sponsor with no additional cost to you or your insurance company. " Pretty clear to me. Here is where things get tricky to interpret and I believe are misleading at worst and in need of clarification at a minimum. " Under normal circumstances you would have physician appointments and undergo similar lab and scan procedures on the same schedule. " OH yeah... says who? CT scans every three months? Dr. Byrd has never suggested I get CT scanned in spite of massive node involvement going back to 2008. That does not mean that some oncologists somewhere might want frequent scanning. " This is known as standard of care, and therefore you and/or your insurance company will be billed for the study doctor visits and tests. " Frequent CT scanning would never be a part of this boy's " standard of care " . Even if PCI may play a part in my current heart problems for instance, I believe it reasonable that my heart health care costs be mine or my insurance company's responsibility because I had prior evidence of heart issues before taking PCI. There are gray areas in the arena of causation and need regarding problems and testing but clearly the frequency of CT scanning is for the benefit of the pharma company in its effort to get drug approval. Yes, it is expensive to get a drug from conception to being approved (estimated 800 million) but what we are not told is that half that amount is drug promotion. (info from LRF Brooklyn Conference 2009) Costs should not only be judged by dollar amounts alone, for there are human health costs to the unfortunate Trial participants who may be crippled or die from unanticipated side effects. Additional financial pressures, forced often unexpectedly, on Trial participants are unacceptable. What do you think? WWW - Lab-Rat in training Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.